SFX by Ex Libris Inc.

Title:	Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance
Source:	Nucleic Acids Research [0305-1048] Rivera-Gonzalez, G C yr:2012

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kroon, P. "JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells." Cancer research 73.16 (2013): 5288-98.
description	2.	Phatak, E A M M. "Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer." Amino acids 44.1 (2011): 33-44.
description	3.	Musgrove, Elizabeth A. "Cyclin D as a therapeutic target in cancer." Nature Reviews. Cancer 11.8 (2011): 558-572.
description	4.	Yu, Q. "Specific protection against breast cancers by cyclin D1 ablation." Nature 411.6841 (2001): 1017-21.
description	5.	Lin, Hemant K. "Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma." Clinical cancer research 19.24 (2013): 6716-6729.
description	6.	Bergthorsson, Jon T. "Endothelial-rich microenvironment supports growth and branching morphogenesis of prostate epithelial cells." The Prostate 73.8 (2013): 884-96.
description	7.	Sundvall, K. "Function of ERBB4 is determined by alternative splicing." Cell cycle 10.16 (2011): 2647-2657.
description	8.	Mimori, T. "TGM2 Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer." Annals of Surgical Oncology 17.4 (2010): 967-972.
description	9.	Malumbres, M. "Cell cycle, CDKs and cancer: a changing paradigm." Nature reviews. Cancer 9.3 (2009): 153-66.
description	10.	Montgomery, J S K. "The androgen receptor gene and its influence on the development and progression of prostate cancer." The Journal of pathology 195.2 (2001): 138-46.
description	11.	Matthews, J. "Estrogen signaling: a subtle balance between ER alpha and ER beta." Molecular interventions 3.5: 281-292.
description	12.	Dai, Y. "Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents." Current oncology reports 6.2: 123-130.
description	13.	Baselga, J. "Targeting Tyrosine Kinases in Cancer: The Second Wave." Science 312.5777 (2006): 1175-1178.
description	14.	Jensen, Lars Juhl J. "Co-evolution of transcriptional and posttranslational cell-cycle regulation." Nature 443.7111 (2006): 594-597.
description	15.	Levine, Arnold J. "The first 30 years of p53: growing ever more complex." Nature Reviews. Cancer 9.10 (2009): 749-758.
description	16.	Lin, C. "Transcriptional Amplification in Tumor Cells with Elevated c-Myc." Cell 151.1 (2012): 56-67.
description	17.	Gustafsson, Jan-Ake A. "Estrogen receptor beta: an overview and update." Nuclear receptor signaling 6.1 (2008).
description	18.	Geng, Y. "Cyclin E ablation in the mouse." Cell 114.4 (2003): 431-443.
description	19.	Bishop, J M M. "Molecular themes in oncogenesis." Cell 64.2 (1990): 235-48.
description	20.	Green, A. "The potential role of ERβ isoforms in the clinical management of breast cancer." Histopathology 53.4 (2008): 374-380.